| Name | Title | Contact Details |
|---|
Fusion Public Relations is a New York, NY-based company in the Business Services sector.
Sales Consultants of Glen Rock is a Oakland, NJ-based company in the Business Services sector.
Coastal Marine Builders is a Bay Minette, AL-based company in the Business Services sector.
TailorCare is an evidence-based, clinically-designed care navigation program that provides deeply personal support to patients living with joint, back, and muscle pain. We develop custom care plans for patients unique needs, empower them to make informed health decisions, and guide them on their path to feeling better, faster.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.